After 16 h, when the respiratory rate had recovered and reached an equilibrium (Fig. 1A, phase II), whole cell respiration was further dissected using respiratory inhibitors (Supplemental Fig. S2A). Total oxygen consumption rate, after addition of carbonyl cyanide m-chlorophenylhydrazone to remove adenylate control, was unchanged by rotenone treatment when expressed on a cell dry weight basis. Addition of 1 mm n-propyl gallate (nPG) to inhibit the AOX pathway showed that maximal respiration through the COX pathway was unchanged by rotenone treatment (Supplemental Fig. S2A). Blue-native PAGE (BN-PAGE) separation of respiratory complexes and detection of NADH dehydrogenase activity revealed that complex I was present and active in mitochondria isolated from rotenone-treated cells (Supplemental Fig. S2B), consistent with the evidence that rotenone is a reversible inhibitor and is lost during mitochondrial isolation (Singer, 1979). These gels also showed that the other classic mitochondrial OxPhos complexes were present and had similar total protein stain intensity in both control and rotenone-treated samples. This is consistent with the fact that there were scarcely any transcriptional responses to rotenone treatment by any of the mitochondrial (Supplemental Fig. S3) or nuclear genes encoding components of the OxPhos complexes (Table I
Changes in expression of nucleus-encoded genes for mitochondrial proteins following 3 and 12 h of rotenone treatment
A set of 556 transcripts for nucleus-encoded mitochondrial proteins were extracted from ATH1 microarray data and placed in 18 functional groups. Significant changes in the expression of each group are reported based on Benjamini-Hochberg correction of P values calculated by the Wilcoxon rank sum test. NS, P > 0.05. Details of genes in each category are given in Supplemental Table S2.
Category . | 3 h . | . | 12 h . | . | ||
---|---|---|---|---|---|---|
. | P . | Regulation . | P . | Regulation . | ||
Complex I | NS | – | NS | – | ||
Complex II | NS | – | NS | – | ||
Complex III | NS | – | NS | – | ||
Complex IV | NS | – | NS | – | ||
ATP synthase | NS | – | NS | – | ||
Alternative pathways | NS | – | 5.83E-05 | Up | ||
Protein import and fate | NS | – | 3.33E-05 | Up | ||
Heat shock proteins and chaperonin | NS | – | 3.33E-05 | Up | ||
Stress-responsive proteins | NS | – | NS | – | ||
TCA cycle | NS | – | NS | – | ||
General metabolism | 6.89E-04 | Up/down | 3.30E-07 | Up | ||
Translation | 0.01836 | Down | NS | – | ||
Signaling and structure | NS | – | 3.30E-07 | Up | ||
Carrier and transporter | NS | – | 0.028826 | Up/down | ||
DNA replication and transcription | NS | – | 1.46E-04 | Up | ||
Photorespiration and C1 metabolism | 2.41E-04 | Down | NS | – | ||
Unknown proteins | NS | – | NS | – |
Category . | 3 h . | . | 12 h . | . | ||
---|---|---|---|---|---|---|
. | P . | Regulation . | P . | Regulation . | ||
Complex I | NS | – | NS | – | ||
Complex II | NS | – | NS | – | ||
Complex III | NS | – | NS | – | ||
Complex IV | NS | – | NS | – | ||
ATP synthase | NS | – | NS | – | ||
Alternative pathways | NS | – | 5.83E-05 | Up | ||
Protein import and fate | NS | – | 3.33E-05 | Up | ||
Heat shock proteins and chaperonin | NS | – | 3.33E-05 | Up | ||
Stress-responsive proteins | NS | – | NS | – | ||
TCA cycle | NS | – | NS | – | ||
General metabolism | 6.89E-04 | Up/down | 3.30E-07 | Up | ||
Translation | 0.01836 | Down | NS | – | ||
Signaling and structure | NS | – | 3.30E-07 | Up | ||
Carrier and transporter | NS | – | 0.028826 | Up/down | ||
DNA replication and transcription | NS | – | 1.46E-04 | Up | ||
Photorespiration and C1 metabolism | 2.41E-04 | Down | NS | – | ||
Unknown proteins | NS | – | NS | – |
Changes in expression of nucleus-encoded genes for mitochondrial proteins following 3 and 12 h of rotenone treatment
A set of 556 transcripts for nucleus-encoded mitochondrial proteins were extracted from ATH1 microarray data and placed in 18 functional groups. Significant changes in the expression of each group are reported based on Benjamini-Hochberg correction of P values calculated by the Wilcoxon rank sum test. NS, P > 0.05. Details of genes in each category are given in Supplemental Table S2.
Category . | 3 h . | . | 12 h . | . | ||
---|---|---|---|---|---|---|
. | P . | Regulation . | P . | Regulation . | ||
Complex I | NS | – | NS | – | ||
Complex II | NS | – | NS | – | ||
Complex III | NS | – | NS | – | ||
Complex IV | NS | – | NS | – | ||
ATP synthase | NS | – | NS | – | ||
Alternative pathways | NS | – | 5.83E-05 | Up | ||
Protein import and fate | NS | – | 3.33E-05 | Up | ||
Heat shock proteins and chaperonin | NS | – | 3.33E-05 | Up | ||
Stress-responsive proteins | NS | – | NS | – | ||
TCA cycle | NS | – | NS | – | ||
General metabolism | 6.89E-04 | Up/down | 3.30E-07 | Up | ||
Translation | 0.01836 | Down | NS | – | ||
Signaling and structure | NS | – | 3.30E-07 | Up | ||
Carrier and transporter | NS | – | 0.028826 | Up/down | ||
DNA replication and transcription | NS | – | 1.46E-04 | Up | ||
Photorespiration and C1 metabolism | 2.41E-04 | Down | NS | – | ||
Unknown proteins | NS | – | NS | – |
Category . | 3 h . | . | 12 h . | . | ||
---|---|---|---|---|---|---|
. | P . | Regulation . | P . | Regulation . | ||
Complex I | NS | – | NS | – | ||
Complex II | NS | – | NS | – | ||
Complex III | NS | – | NS | – | ||
Complex IV | NS | – | NS | – | ||
ATP synthase | NS | – | NS | – | ||
Alternative pathways | NS | – | 5.83E-05 | Up | ||
Protein import and fate | NS | – | 3.33E-05 | Up | ||
Heat shock proteins and chaperonin | NS | – | 3.33E-05 | Up | ||
Stress-responsive proteins | NS | – | NS | – | ||
TCA cycle | NS | – | NS | – | ||
General metabolism | 6.89E-04 | Up/down | 3.30E-07 | Up | ||
Translation | 0.01836 | Down | NS | – | ||
Signaling and structure | NS | – | 3.30E-07 | Up | ||
Carrier and transporter | NS | – | 0.028826 | Up/down | ||
DNA replication and transcription | NS | – | 1.46E-04 | Up | ||
Photorespiration and C1 metabolism | 2.41E-04 | Down | NS | – | ||
Unknown proteins | NS | – | NS | – |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.